Table 3 Means, standard deviations and effect sizes for symptom related outcomes, observed data with imputations, n = 19
Measure | Pre-treatment | Post-treatment | Three-month Follow-up | Within Group Effect Size d (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|
M | SD | M | SD | M | SD | Pre-post | Pre-Fu3 | Post-Fu3 | |
ISI | 15.4 | 4.2 | 10.9 | 6.0 | 8.6 | 4.7 | 0.84*** (0.31–1.37) | 1.52*** (0.87–2.18) | 0.42 (−0.12–0.95) |
ASRS (total) | 43.2 | 13.2 | 40.2 | 15.7 | 38.7 | 13.0 | 0.20 (−0,12–0.51) | 0.34* (0.05–0.62) | 0.09 (−0.10–0.29) |
Inattention | 23.7 | 7.2 | 22.2 | 8.1 | 21.6 | 6.7 | 0.19 (−0.01–0.39) | 0.31* (0.05–0.57) | 0.08 (− 0.18–0.34) |
Hyperactivity | 19.9 | 7.9 | 17.6 | 8.4 | 16.5 | 6.9 | 0.28* (0.00–0.55) | 0.44*** (0.20–0.69) | 0.14 (−0.07–0.35) |